Skip to content Skip to footer
Subscribe Now
Diagnostics Companies Based Top 20 2019
TOP 20
Top 20 Diagnostics Companies Based on 2019 Revenue
Diagnostics has emerged as one of the largest and fastest-growing segments with evolving diseases. The segment has played a vital role in diagnosing growing and ageing global population with increasing health expenditure and more prevalent lifestyle ailments including obesity- cancer- and cardiovascular diseases. Our team at PharmaShots has compiled a list of top 20 diagnostics companies based…
June 12, 20200Comments
Insights+ Key Biosimilars Events of May 2020
INSIGHTS+
Insights+ Key Biosimilars Events of May 2020
Biosimilars are developed to be highly similar versions of approved biologics in terms of safety, purity, and potency Fresenius Kabi expanded its footprints with the acceptance of MAA and BLA of its MSB11455 (biosimilar, pegfilgrastim) in the EU and the US respectively, and also signed an agreement with Medec to commercialize Idacio (adalimumab, biosimilar) in…
June 5, 20200Comments
Insights+ Key Biosimilars Events of April 2020
INSIGHTS+
Insights+ Key Biosimilars Events of April 2020
Biosimilars are developed to be highly similar versions of approved biologics in terms of safety, purity, and potency. Biosimilars are expected to be a cost-effective alternative to the high-priced branded biologics, offering significant and much-needed cost savings to both payers and the patients. Hence, the providers are more likely to adopt biosimilars as a 'reference…
May 8, 20200Comments

Sign Up to Our Newsletter

Be the first to know the latest updates

[mc4wp_form id="13387" element_id="style-1"]